Skip to main content
NewslettersWatchlist

Rubicon Organics Inc(ROMJ-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.360
Day High0.365
Open:0.365
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Automated Summaries - The Globe and Mail
Closing Bell: Rubicon Organics Inc down on Monday (ROMJ)
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics Reports 2023 Financial Results
GlobeNewswire
Rubicon Organics to Report Q4 2023 Results
GlobeNewswire
Rubicon Organics Brings 1964 Supply Co. Cannabis-Infused Poutine Sauce to Quebec
GlobeNewswire
Rubicon Organics Announces the Appointment of Chief Executive Officer and Chief Financial Officer, and Grants RSUs
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ROMJ)
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics Grants DSUs and Options
GlobeNewswire
Rubicon Organics Celebrates Double Triumph at 2023 KIND Magazine’s Awards
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ROMJ)
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics Reports Third Quarter 2023 Financial Results
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ROMJ)
GlobeNewswire
Rubicon Organics to Report Q3 2023 Results
AI-generated - The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics™ Launches Wildflower™ Edibles Crafted with CBD, CBN & CBG
GlobeNewswire
Rubicon Organics Announces Third Annual Environmental, Social, & Governance Report & Board Appointment
GlobeNewswire
Rubicon Organics Announces the Results of Annual General Meeting
GlobeNewswire
Rubicon Organics to Hold Annual General Meeting
GlobeNewswire
Rubicon Organics Reports Second Quarter 2023 Financial Results
GlobeNewswire
Rubicon Organics™ Announces New Product Launches Under Simply Bare™ Organic and 1964 Supply Co™ and the Further Expansion of Canada's Leading Topical Brand, Wildflower™
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
GlobeNewswire
Rubicon Organics to Report Q2 2023 Results
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)
The Globe and Mail
Rubicon Organics: Top 10 Undervalued Drug Manufacturers Industry Stocks (ROMJ)

Profile

Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.